| Anthony Joseph Reese, REGISTERED NURSE | |
|
275 W Queen St, Hampton, VA 23669-4005 | |
| (757) 374-8591 | |
| Not Available |
| Full Name | Anthony Joseph Reese |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | 275 W Queen St, Hampton, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023663697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP1600X | Counselor - Pastoral | (* (Not Available)) | Secondary |
| 163W00000X | Registered Nurse | 1106060 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Joseph Reese, REGISTERED NURSE 275 W Queen St, Hampton, VA 23669-4005 Ph: (757) 374-8591 | Anthony Joseph Reese, REGISTERED NURSE 275 W Queen St, Hampton, VA 23669-4005 Ph: (757) 374-8591 |
News Archive
Isotechnika Pharma Inc. announced today that Lux Biosciences, Inc. has commenced its pivotal Phase 3 trial using voclosporin for the treatment of non-infectious uveitis, a leading cause of vision loss and long-term disability.
Growth rates of lung cancers found by annual rounds of computed tomography (CT) screening are important for determining the usefulness and frequency of screening, as well as for determining the treatment.
A meta-analysis of clinical trial and real-world data suggests that drotrecogin alfa may in fact reduce mortality in patients with severe sepsis.
Antibody tests that can detect whether people have been exposed to new variants of Covid-19 have been developed by the University of Aberdeen, in collaboration with biotechnology group Vertebrate Antibodies Ltd and NHS Grampian.
› Verified 3 days ago